share_log

Legend Biotech | 6-K: Legend Biotech Reports Second Quarter 2023 Results and Unaudited Interim Condensed Consolidated Financial Statements as of June 30, 2023 and for the six months ended June 30, 2023 and 2022

SEC announcement ·  Aug 15, 2023 06:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more